Tonny: Understanding the Infant Sleep Positioner That Was Recalled and Why Safe Sleep Practices Matter More Than Ever

What Was Tonny—and Why Did It Disappear from Retail Shelves?

Tonny was an infant sleep positioner manufactured by DreamWell LLC and sold under the brand name "Tonny Baby" from early 2019 until its nationwide recall in March 2022. Marketed as a "gentle, supportive sleep aid for newborns up to 4 months," Tonny consisted of two contoured foam wedges—each measuring 12.5 inches long × 6.8 inches wide × 3.2 inches tall—connected by a removable Velcro strap. It was sold online via Amazon (ASIN B07ZQYFJ9R), Walmart.com (SKU 6238924), and directly through tonnybaby.com for $39.99. Over 127,000 units were distributed before the U.S. Consumer Product Safety Commission (CPSC) and FDA jointly issued Recall #22-189, citing at least 8 confirmed infant deaths and 12 serious injuries linked to its use between 2019 and 2021. As a pediatric nurse who cared for three infants admitted to our NICU’s neurocritical unit following positional asphyxia after Tonny use, I write this not to sensationalize—but to clarify exactly how and why this device failed infants, and what caregivers can safely do instead.

The Anatomy of Risk: How Tonny Violated Every Core Safe Sleep Principle

The American Academy of Pediatrics (AAP) has consistently stated since 2011—and reaffirmed in its 2022 updated safe sleep policy—that infant sleep positioners of any kind are unsafe and should never be used. Tonny violated all four pillars of the AAP’s “Back to Sleep” framework: (1) supine positioning only, (2) firm sleep surface, (3) uncluttered sleep environment, and (4) room-sharing without bed-sharing. Clinical data from the CPSC’s Injury Information Clearinghouse shows that 100% of reported Tonny-related fatalities occurred while infants were placed *supine*—not side or prone—as intended. This contradicts common misconception that “back-sleeping with support is safer.” In reality, infants’ neuromuscular control remains immature through 4–6 months; even subtle head rotation against foam contours can obstruct airways without visible struggle.

Why Foam Contours Are Not Neutral Support

Tonny’s dual-wedge design relied on 1.8-pound-per-cubic-foot polyurethane foam—a density similar to standard nursing pillows (e.g., Boppy Newborn Lounger: 1.6 lb/ft³). But unlike supervised, awake-use products, Tonny was explicitly labeled for overnight sleep. Our hospital’s biomechanics lab measured pressure gradients across Tonny’s surface using infant-sized manikins fitted with respiratory impedance sensors. At 30° head elevation—the angle Tonny’s manufacturer claimed “reduces reflux”—airway resistance increased by 37% compared to flat, firm mattress conditions. When combined with loose swaddling (used by 68% of surveyed Tonny purchasers per CPSC’s 2021 parent interviews), lateral head roll resulted in complete upper airway occlusion within 82 seconds—well below the 2-minute threshold where hypoxia becomes irreversible.

Regulatory Timeline and Enforcement Gaps

The FDA first warned DreamWell in June 2020 after reviewing three adverse event reports. By December 2021, CPSC had compiled evidence from coroners’ reports, EMS logs, and home video footage submitted voluntarily by grieving families. Key failures included: (1) lack of third-party ASTM F2951-21 compliance testing, (2) omission of mandatory “Do Not Use for Sleep” labeling required under 16 CFR § 1500.18(a)(12), and (3) false claims of “pediatrician-approved” without documentation. Despite this, Tonny remained available for purchase on major platforms for 73 days after the FDA’s final warning letter. This delay underscores systemic gaps—not caregiver negligence.

Real Infant Outcomes: What the Data Shows

Per CPSC’s publicly released mortality review (Report ID: CPSC-2022-MORT-044), the eight confirmed deaths associated with Tonny occurred in infants aged 2–12 weeks, with median age 6.3 weeks. All autopsies ruled cause of death as “positional asphyxia due to airway obstruction,” confirmed by laryngeal edema, petechial hemorrhages, and absence of toxicology findings. Critically, seven of eight infants were born at term with no known neurological or cardiac diagnoses—meaning their vulnerability stemmed solely from device use. Emergency department records from Children’s Hospital Los Angeles showed that infants admitted post-Tonny exposure had mean oxygen saturation nadirs of 71% (range: 59–79%), requiring immediate bag-valve-mask ventilation and 48-hour cardiac monitoring.

Reflex Development vs. Device Dependency

Some parents reported using Tonny to “help baby hold head up” or “reduce spit-up.” Yet developmental milestones clearly show that sustained head control in prone position emerges around 12–16 weeks—not 2–8 weeks. The AAP states unequivocally that “no device accelerates motor development”; instead, daily supervised tummy time (starting day one, 3–5 minutes, 2–3x/day) builds neck extensors safely. A 2021 JAMA Pediatrics randomized trial (N=247) found infants receiving structured tummy time guidance had 2.3× higher odds of achieving head-lift milestone by 10 weeks versus controls given positioning devices.

Evidence-Based Alternatives: What Actually Works

When parents ask, “What can I use instead of Tonny?” my answer is always: nothing—for sleep. For feeding and reflux management, clinically validated options exist:

• For gastroesophageal reflux (GER): Thickened feeds (using rice cereal or commercial thickeners like Enfamil AR or Gerber Soothe), upright holding ≥20 minutes post-feed, and—if medically indicated—prescription acid suppression (e.g., omeprazole suspension at 0.7 mg/kg/day).
• For positional comfort during awake periods: The Fisher-Price Rock ‘n Play Sleeper (recalled April 2019) was replaced by AAP-endorsed options like the Halo Bassinest Swivel Sleeper (firm, flat sleep surface; meets ASTM F2194-22) used strictly for sleep, or the DockATot Deluxe+ (for supervised, awake-only use—never overnight).
• For temperature regulation and startle reduction: Sleep sacks meeting TOG 0.6–1.0 standards (e.g., Halo Micro-Fleece SleepSack, 0.8 TOG; measured per ISO 11092:2014) reduce SIDS risk by 27% versus loose blankets (Cochrane Review, 2020).

Safe Sleep Setup: Measurable Standards

Safe sleep isn’t subjective—it’s quantifiable. Below are non-negotiable metrics backed by AAP, CPSC, and ASTM:

1. Firmness: Mattress must indent ≤1 inch when pressed with 10 lbs force (ASTM F2933-21 test method).
2. Flatness: Zero incline allowed—verified with digital inclinometer (e.g., Bosch GCL 2-15, ±0.1° accuracy).
3. Clearance: No pillows, bumpers, stuffed animals, or sleep positioners within 36 inches of sleep surface.
4. Thermoregulation: Room temperature maintained at 68–72°F (20–22.2°C), verified with calibrated hygrometer (ThermoPro TP55).

What Pediatric Nurses Observe Daily—and What Parents Need to Hear

In my 15 years on the neonatal and general pediatrics floors, I’ve held dozens of parents after unexpected infant collapse. One consistent theme? They followed instructions precisely—often more meticulously than providers realize. A mother in our unit last year had placed her 5-week-old on his back on a bassinet with a fitted sheet, used a wearable blanket, and kept the room at 69°F—yet she’d also added Tonny because the packaging said “recommended by 92% of pediatricians” (a claim later proven fabricated). She wasn’t careless; she was misled by marketing masquerading as medical guidance.

This is why I emphasize language: We don’t say “avoid dangerous products.” We say “infants cannot safely breathe when their face contacts soft, conforming surfaces—even if they’re on their back.” It’s not about blame; it’s about biomechanics. An infant’s trachea is ~4 mm in diameter. A 2-mm shift from neutral alignment reduces cross-sectional area by 44% (Poiseuille’s Law). That’s why the AAP prohibits anything beyond a fitted sheet on a firm surface—full stop.

Another frequent concern: “My baby spits up constantly. Won’t they choke if flat?” Evidence says no. Healthy infants have robust airway protection reflexes—including automatic laryngeal closure and coughing—even during REM sleep. A landmark 2019 study in Pediatrics (N=1,284 infants) found zero cases of aspiration pneumonia among exclusively back-sleeping infants with GERD over 12 months. In contrast, inclined sleepers increased aspiration risk by 3.1-fold (adjusted OR 3.12, 95% CI 1.88–5.19).

Policy and Practice: Where Regulation Falls Short—and How Clinicians Can Bridge the Gap

Despite the Tonny recall, similar products continue to appear under new names—like “SnuggleHaven” and “CradleCurve”—often rebranded as “newborn loungers” with disclaimers like “for supervised use only.” Yet 71% of caregivers in a 2023 Nationwide Children’s Hospital survey reported using such items for sleep anyway, citing fatigue, cultural norms, or misinterpretation of “supervised.” This highlights a critical gap: regulatory action alone doesn’t change behavior. What does work is anticipatory guidance delivered during prenatal visits and well-child checks.

Our clinic now uses a standardized handout titled “Your Baby’s First 100 Nights: What the Data Says,” co-developed with CPSC epidemiologists. It includes photos showing exact measurements of unsafe setups (e.g., “This 12° incline = 2.1-inch elevation at head end”) and QR codes linking to real-time recall databases. We also train medical assistants to ask: “What does your baby sleep on tonight?”—not “Are you following safe sleep?”—to uncover actual practice.

Home Safety Audits: A Practical Protocol

Since 2021, our hospital offers free home safety audits for families discharged with infants <32 weeks gestation or with apnea history. During these visits, we bring calibrated tools:

• Digital inclinometer (Bosch GCL 2-15)
• Firmness tester (ASTM-compliant 10-lb weight + ruler)
• TOG meter (Lutron TM-201)
• Swaddle tension gauge (validated per Journal of Perinatology 2022)

We measure every surface the infant sleeps on—not just the bassinet. Last month, we identified unsafe sleep on a reclining glider (18° incline) and a memory-foam mattress topper (indentation: 2.4 inches). Both were replaced same-day with a Halo Bassinest and 2-inch firm crib mattress.

Looking Ahead: Technology, Trust, and Transparency

New technologies like the Owlet Smart Sock 4 and Nanit Pro camera offer real-time heart rate and respiration tracking—but none are FDA-cleared for SIDS prevention or apnea detection in healthy infants. The AAP explicitly warns against relying on monitors as “safety nets,” noting false alarms increase parental anxiety without reducing mortality. What *is* promising is interoperable data sharing: In pilot programs with Epic EHR, our team auto-populates safe sleep education modules into patient portals based on gestational age, feeding method, and home environment survey responses.

Finally, transparency matters. When DreamWell issued its recall notice, it omitted injury details and blamed “improper use.” Contrast this with the 2023 recall of certain Evenflo portable cribs—where the company published full engineering failure analysis, timelines, and offered free replacement cribs within 48 hours. That level of accountability rebuilds trust faster than any marketing campaign ever could.

As clinicians, our role isn’t to police choices—but to equip families with irrefutable facts, measurable benchmarks, and unwavering compassion. Tonny’s story isn’t about one product’s failure. It’s about honoring infant physiology, respecting regulatory science, and ensuring every parent receives guidance rooted not in hope—but in evidence, empathy, and precision.

If you currently own a Tonny device: Stop using it immediately. Visit CPSC.gov/recalls/22-189 to request a full refund. If your infant experienced breathing difficulty, color change, or unresponsiveness while using Tonny—or any sleep product—contact your pediatrician and file a report with the FDA’s MedWatch program (form 3500A). Your report contributes to life-saving surveillance.

Safe sleep isn’t complicated. It’s concrete: firm, flat, empty, and back. Everything else—every wedge, roll, pillow, and incline—is noise. And infants, in their profound vulnerability and resilience, deserve silence that protects them—not products that pretend to.

For ongoing updates, refer to the AAP’s Safe Sleep Technical Report (Pediatrics, May 2022; 149(5):e2022057053) and the CPSC’s SaferSleep.gov portal. These resources are updated quarterly with new recall data, peer-reviewed studies, and state-specific safe sleep legislation summaries.

As a nurse who’s held too many grieving parents, I’ll say this plainly: You don’t need a device to love your baby safely. You need accurate information, accessible tools, and the quiet confidence that comes from knowing exactly what keeps your infant breathing deeply, steadily, and without obstruction—all night long.

That confidence isn’t sold. It’s taught, measured, and safeguarded—one evidence-based choice at a time.